Circulating Humoral Factors and Lymphocyte Subsets as Markers for Radiation Pulmonary Injury

Theodore Robnett, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 1 de noviembre del 1999

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC

Mar 4, 2015

L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival

Hematologic Markers Predict Nasopharyngeal Cancer Survival

Sep 22, 2015

High neutrophil-lymphocyte, platelet-lymphocyte ratios tied to shorter survival

Tumor Cells May Be Marker of Prostate Cancer Survival

Dec 1, 2015

Changes in circulating tumor cell count after treatment associated with increased mortality